A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome | MicrobiomeTrials← Back to trialsNCT05419492
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-05-14Est. Completion: 2028-01
Enrollment target: 47 participants Locations- UCSF Benioff Children's Hospitals, San Francisco, California, United States
- Colorado Children's Hospital, Aurora, Colorado, United States
- Nicklaus Children's Hospital, Miami, Florida, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Mott Children's Hospital, Ann Arbor, Michigan, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Duke Children's Hospital & Health Center, Durham, North Carolina, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Oregon Health and Science University (OSHU), Portland, Oregon, United States
- Cook Children's Medical Center, Fort Worth, Texas, United States
- The Royal Children's Hospital, Melbourne, Australia
- Queen Elizabeth Hospital, Glasgow, United Kingdom
- Great Ormond Street Hospital, London, United Kingdom
Other microbiome trials you might be interested in
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol …
Little Rock, United StatesEst. completion Aug 1, 2027
Dravet Syndrome
This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, …
Little Rock, United StatesEst. completion Aug 21, 2026